Ignite Creation Date:
2024-05-06 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03692988
Status:
COMPLETED
Last Update Posted:
2021-06-15
First Post:
2018-09-27
Brief Title:
Dignity Therapy for Patients With Early Dementia and Their Family
Sponsor:
University of Zurich
Organization:
University of Zurich
Study Overview
Official Title:
Dignity Therapy a Brief Psychological and Existential Intervention for Patients With Early Dementia and Their Family A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DTD
Brief Summary:
Developed by Harvey M Chochinov in 2005 Dignity Therapy DT invites individuals with life-limiting illnesses to reflect on matters of importance to them and compiles them in a narrative document for the patient to share DT has shown to improve quality of life and a sense of dignity as well as supporting relatives in the process of grievance Featuring a gradual loss of memories of the past decline of cognitive functions and awareness of self dementia can be regarded as a life-limiting or life-changing illness which is often accompanied by significant psychological stress DT may help patients and their relatives reduce this stress Yet no studies have been conducted to determine the benefits of DT in patients with early stage dementia ESD This study investigates the feasibility and acceptance of DT by patients with very mild dementia CDR 05 - 15 and their relatives as well as their overall satisfaction This study further seeks to determine the effects of DT on sense of dignity quality of life dyadic coping and levels of anxiety and depression in a randomized controlled design
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None